One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Time to Stop the Fibromyalgia Criteria Wars and Refocus on Identifying and Treating Individuals With This Type of Pain Earlier in Their Illness
Daniel Clauw
doi : 10.1002/acr.24198
Volume 73, Issue 5 p. 613-616
Modified 2016 American College of Rheumatology Fibromyalgia Criteria, the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks–American Pain Society Pain Taxonomy, and the Prevalence of Fibromyalgia
Winfried H?user Elmar Br?hler Jacob Ablin Frederick Wolfe
doi : 10.1002/acr.24202
Vol. 73, Issue 5,p. 617–625
Defining Pain That Does Not Interfere With Activities Among Rheumatoid Arthritis Patients
Yvonne C. Lee Patricia Katz Amanda Quebe Luna Sun Himanshu Patel Carol L. Gaich Kaleb Michaud
doi : 10.1002/acr.24170
Volume 73, Issue 5 p. 626-632
The objectives of this study were to: 1) characterize the distribution of noninterfering pain (defined as the pain intensity level at which individuals can function without interference) across different aspects of life among patients with rheumatoid arthritis (RA), and 2) identify clinical characteristics associated with differing levels of noninterfering pain.
Predictors of Smoking Cessation in Patients With Rheumatoid Arthritis in Two Cohorts: Most Predictive Health Care Factors
Maria Schletzbaum Xing Wang Robert Greenlee Megan E. Piper Christie M. Bartels
doi : 10.1002/acr.24154
Volume 73, Issue 5 p. 633-639
Recognizing smoking as a risk factor for rheumatoid arthritis (RA) severity, the present study was undertaken to evaluate patient? and health care–level predictors of smoking cessation in patients with RA to guide implementation of smoking cessation interventions.
A Population?Based Approach to Reporting System–Level Performance Measures for Rheumatoid Arthritis Care
Claire E. H. Barber Deborah A. Marshall Elena Szefer Cheryl Barnabe Natalie J. Shiff Vivian Bykerk Joanne Homik J. Carter Thorne Vandana Ahluwalia Susanne Benseler Dianne Mosher Marinka Twilt Diane Lacaille
doi : 10.1002/acr.24178
Volume 73, Issue 5 p. 640-648
To operationalize and report on nationally endorsed rheumatoid arthritis (RA) performance measures (PMs) using health administrative data for British Columbia (BC), Canada.
Outcomes Reported in Prospective Long?Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review
Maria A. Lopez?Olivo Richard J. Zogala Jude des Bordes Natalia V. Zamora Robin Christensen Davesh Rai Niti Goel Loreto Carmona Gregory Pratt Vibeke Strand Maria E. Suarez?Almazor
doi : 10.1002/acr.24163
Volume 73, Issue 5 p. 649-657
Prospective long?term observational studies (LOS) in rheumatoid arthritis (RA) lack a core set of universally collected outcome measures, particularly patient?centered outcomes, precluding accurate comparisons across studies. Our aim was to identify long?term outcome measures collected and reported in these studies.
Findings on Coronary Angiographies in Patients With Rheumatoid Arthritis and Ischemic Heart Disease: Are They Different From Patients Without Rheumatoid Arthritis?
Marie Holmqvist ?ngla Mantel Solveig W?llberg?Jonsson Stefan James Tomas Jernberg Johan Askling
doi : 10.1002/acr.24214
Volume 73, Issue 5 p. 658-665
Patients with rheumatoid arthritis (RA) are at increased risk of coronary artery disease (CAD) and seem to develop more severe acute coronary syndromes (ACS) than the general population. Because few studies have investigated the CAD distribution in the context of acute or stable CAD in RA, the objective was to investigate whether this risk is due to a different distribution and severity of coronary stenoses (versus non?RA), resulting in clinical manifestation of CAD.
Association of Rural Setting With Poorer Disease Outcomes for Patients With Rheumatic Diseases: Results From a Systematic Review of the Literature
Rosemary J. Hollick Gary J. Macfarlane
doi : 10.1002/acr.24185
Volume 73, Issue 5 p. 666-670
To assess whether clinical and patient?reported outcomes are poorer for individuals with inflammatory and noninflammatory rheumatic diseases living in rural locations.
“The Financial Impact Is Depressing and Anxiety Inducing”: A Qualitative Exploration of the Personal Financial Toll of Arthritis
Danielle Berkovic Darshini Ayton Andrew M. Briggs Ilana N. Ackerman
doi : 10.1002/acr.24172
Volume 73, Issue 5 p. 671-679
The financial experience faced by working?age people with arthritis includes living below the poverty line for many. Financial distress among people with arthritis is known to contribute to poorer health outcomes, including high psychological distress and more severe pain. Despite the demonstrated societal cost of arthritis care and management, the personal costs borne by the individual are not well understood. The aim of this study was to explore the perceived financial impacts of living with arthritis among younger adults (defined as those ages 18–50 years).
Health Care Utilization for Musculoskeletal Issues During the Prediagnosis Period in Psoriatic Arthritis: A Population?Based Study
Lihi Eder Karen Tu Cheryl F. Rosen Raed Alhusayen Stephanie Y. Cheng Jacqueline Young Willemina Campbell Sasha Bernatsky Dafna D. Gladman J. Michael Paterson Jessica Widdifield
doi : 10.1002/acr.24146
Volume 73, Issue 5 p. 680-686
Information about the prediagnosis period in psoriatic arthritis (PsA) is limited. The present study was undertaken to compare health care utilization related to musculoskeletal issues during a 5?year period prior to the diagnosis of PsA versus that of subjects with no prior inflammatory arthritis within a primary care setting.
Relationship Between Self?Reported Restless Sleep and Objectively Measured Physical Activity in Adults With Knee Osteoarthritis
Abigail L. Gilbert Jungwha Lee Jing Song Pamela A. Semanik Linda S. Ehrlich?Jones C. Kent Kwoh Dorothy D. Dunlop Rowland W. Chang
doi : 10.1002/acr.23581
Volume 73, Issue 5 p. 687-692
Despite the numerous health benefits of physical activity, inactivity is endemic among adults with knee osteoarthritis (OA). Because sleep quality may be a target in order to improve physical activity behavior, we investigated the cross?sectional relationship between restless sleep and physical activity in participants with or at risk for knee OA.
Precision Medicine Approach to Develop and Internally Validate Optimal Exercise and Weight?Loss Treatments for Overweight and Obese Adults With Knee Osteoarthritis: Data From a Single?Center Randomized Trial
Xiaotong Jiang Amanda E. Nelson Rebecca J. Cleveland Daniel P. Beavers Todd A. Schwartz Liubov Arbeeva Carolina Alvarez Leigh F. Callahan Stephen Messier Richard Loeser Michael R. Kosorok
doi : 10.1002/acr.24179
Volume 73, Issue 5 p. 693-701
To apply a precision medicine approach to determine the optimal treatment regime for participants in an exercise (E), dietary weight loss (D), and D + E trial for knee osteoarthritis that would maximize their expected outcomes.
Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus Among Patients With Systemic Lupus Erythematosus: A Population?Based Study
Shahrzad Salmasi Eric C. Sayre J. Antonio Avi?a?Zubieta John M. Esdaile Mary A. De Vera
doi : 10.1002/acr.24147
Volume 73, Issue 5 p. 702-706
To evaluate the association between adherence to antimalarials and type 2 diabetes mellitus (DM) in patients with systemic lupus erythematosus (SLE).
Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta?Analysis
Shivani Garg Rachna Unnithan Karen E. Hansen Nathalie Costedoat?Chalumeau Christie M. Bartels
doi : 10.1002/acr.24155
Volume 73, Issue 5 p. 707-716
Despite the pivotal role that hydroxychloroquine (HCQ) plays in treating systemic lupus erythematosus (SLE), less than 50% of patients take HCQ as prescribed. Measurement of HCQ blood levels can help clinicians distinguish nonadherence versus lack of efficacy of HCQ. Our objective was to systematically review publications and perform a meta?analysis to examine the correlation between HCQ levels and 1) nonadherence and 2) Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores, in SLE.
Soluble Flt?1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia
Guilherme R. de Jes?s Marcela I. Lacerda Bruna C. Rodrigues Fl?via C. dos Santos Adriana P. do Nascimento Lu?s Crist?v?o Porto Nilson R. de Jes?s Roger A. Levy Evandro M. Klumb
doi : 10.1002/acr.24360
Volume 73, Issue 5 p. 717-721
To evaluate mean serum levels of vascular endothelial growth factor (VEGF), placental growth factor (PlGF), and soluble Flt?1 (sFlt?1) in pregnant patients with systemic lupus erythematosus (SLE) with inactive disease, active lupus nephritis, and preeclampsia for differential diagnosis between these conditions.
Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature
Nina M. van Leeuwen Jacopo Ciaffi Jan W. Schoones Tom W. J. Huizinga Jeska K. de Vries?Bouwstra
doi : 10.1002/acr.24149
Volume 73, Issue 5 p. 722-731
Microangiopathy and dysregulation of the immune system play important roles in the pathogenesis of systemic sclerosis (SSc). Factors that trigger vascular injury in SSc have not been elucidated so far. We undertook this study to evaluate whether sex or expression of specific antinuclear autoantibodies might associate with the degree of microangiopathy through performance of a systematic review that summarizes what is known about these associations.
Clinical Features of Systemic Sclerosis–Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes
Jessica L. Fairley Dylan Hansen Susanna Proudman Joanne Sahhar Gene?Siew Ngian Jenny Walker Gemma Strickland Michelle Wilson Kathleen Morrisroe Nava Ferdowsi Gabor Major Janet Roddy Wendy Stevens Mandana Nikpour for the Australian Scleroderma Interest Group
doi : 10.1002/acr.24167
Volume 73, Issue 5 p. 732-741
To describe the clinical characteristics and outcomes of systemic sclerosis–mixed connective tissue disease (SSc–MCTD) and SSc overlap syndrome.
Anatomic Distribution of Sacroiliac Joint Lesions on Magnetic Resonance Imaging in Patients With Axial Spondyloarthritis and Control Subjects: A Prospective Cross?Sectional Study, Including Postpartum Women, Patients With Disc Herniation, Cleaning Staff, Runners, and Healthy Individuals
Sengül Seven Mikkel ?stergaard Lone Morsel-Carlsen Inge J. S?rensen Birthe Bonde Gorm Thamsborg Jens J. Lykkegaard Susanne J. Pedersen
doi : 10.1002/acr.24473
Volume 73, Issue 5 p. 742-754
To investigate the anatomic location and distribution of lesions on magnetic resonance imaging (MRI) in the sacroiliac (SI) joints in patients with axial spondyloarthritis (SpA), women with and without postpartum pain (childbirth within 4–16 months), patients with disc herniation, cleaning staff, runners, and healthy persons.
Efficacy and Safety of Pharmacologic Interventions in Patients Experiencing a Gout Flare: A Systematic Review and Network Meta?Analysis
Linan Zeng Anila Qasim Tuhina Neogi John D. Fitzgerald Nicola Dalbeth Ted R. Mikuls Gordon H. Guyatt Romina Brignardello?Petersen
doi : 10.1002/acr.24402
Volume 73, Issue 5 p. 755-764
To compare the relative efficacy and safety of pharmacologic antiinflammatory interventions for gout flares.
Error in Figure 2B of the Article by Kolasinski et al (Arthritis Care Res, February 2020)
doi : 10.1002/acr.24615
Volume 73, Issue 5 p. 764-764
Error in Study Funding Acknowledgment in the Article by Buckley et al (Arthritis Care Res, February 2021)
doi : 10.1002/acr.24614
Volume 73, Issue 5 p. 764-764
